Aromatase inhibitors in the treatment of breast cancer

This publication has 49 references indexed in Scilit:

• Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women
  Journal of Clinical Endocrinology & Metabolism, 1993
• Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours
  European Journal of Cancer and Clinical Oncology, 1991
• Potency and selectivity of the aromatase inhibitor R 76 713. A study in human ovarian, adipose stromal, testicular and adrenal cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• A phase I trial of CGS 16949a. A new aromatase inhibitor
  Cancer, 1990
• 14.ALPHA.-Hydroxyandrost-4-ene-3,6,17-trione as a mechanical-based irreversible inhibitor of estrogen biosynthesis.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
• 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitor
  Journal of Steroid Biochemistry, 1988
• Studies on the mechanism of estrogen biosynthesis in the rat ovary–I
  The Journal of Steroid Biochemistry and Molecular Biology, 1976
• The Mechanism of Estrogen Biosynthesis
  Journal of the American Chemical Society, 1962
• The intermediate steps in the biosynthesis of estrogens from androgens
  Biochemical and Biophysical Research Communications, 1961
• Conversion of 19-hydroxy-Δ4-androstene-3,17-dione to estrone by endocrine tissue
  Biochimica et Biophysica Acta, 1955